Online ISSN: 2331-4737
About Oncoscience
Our mission is to cover the rapidly growing field of cancer research. We aim to focus on emergent topics not currently covered by other journals.
Oncoscience has also a special mission: freeing researchers in oncology from publication costs. It is free for both readers and authors.

Gastrointestinal Toxicity Linked to Targeted Cancer Therapies in the United States

Oncoscience

February 20, 2026
A new paper was published in Volume 13 of Oncoscience on February 6, 2026, titled “Gastrointestinal toxicity of targeted cancer therapies in the United States: Clinicopathologic patterns, FDA safety frameworks, and implications for national patient protection.” continue reading »

New Dual-Action Compound Reduces Pancreatic Cancer Cell Growth

Oncoscience

February 10, 2026
A new research paper was published in Volume 13 of Oncoscience on January 28, 2026, titled “Dual targeting of oncogenic microtubules and mitochondria in PDAC.” continue reading »

5-FU Chemotherapy Linked to Rare Brain Toxicity in Cancer Patient

Oncoscience

February 5, 2026
A new case report was published in Volume 12 of Oncoscience on December 23, 2025, titled “Silent toxicity: A rare case of 5-fluorouracil-induced hyperammonemic encephalopathy.” continue reading »

Early Recognition and Surgical Management Key in Necrotizing Fasciitis of the Head and Neck

Oncoscience

January 29, 2026
A new research perspective was published in Volume 12 of Oncoscience on December 23, 2025, titled “Necrotizing fasciitis of the head and neck – clinical features, diagnostics, and management strategies.” continue reading »